Stockreport

How The CorMedix (CRMD) Investment Story Is Shifting As Analyst Targets Reset [Yahoo! Finance]

CorMedix Inc.  (CRMD) 
NASDAQ:AMEX Investor Relations: cormedix.com
PDF CorMedix is back in focus as analysts reset their price targets, with some moving to $16 from $20, others to $13 from $15, and a few cutting as low as $9. These changes [Read more]